The page lists 18 deliverables related to the research project "ORCHID".
title and desprition | type | last update |
---|---|---|
Organ-on-chip – outlook on the regulatory pathwayIdentify regulatory pathways for different applications and processes of organ-on-chip technology based on existing and novel routes. Identify gaps and shortcomings of existing regulatory processes, together with regulators (e.g. EMA, FDA, national authorities), e.g. in a round table format. Consider regulation at the European level but also include regulation outside Europe and practise in neighbouring/related sectors and applications. Define joint exemplary cases for organ-on-chip -based product innovation trajectories with best practises and suggest actions for regulatory improvements. Programme: H2020-EU.1.2.1. - Topic(s): FETOPEN-03-2017 |
Documents, reports | 2020-04-09 |
White paper on standardizationIn this cross-technology area, standardisation is considered an innovation enabler and accelerator. Identify shortcomings that hamper emerging business models and fast uptake of processes and technologies. This addresses both process/business and technology innovation. Programme: H2020-EU.1.2.1. - Topic(s): FETOPEN-03-2017 |
Documents, reports | 2020-04-09 |
Roadmap• Develop a draft of the roadmap and conduct one review with roadmap contributors and one external review before finalizing it. Programme: H2020-EU.1.2.1. - Topic(s): FETOPEN-03-2017 |
Documents, reports | 2020-04-09 |
Report on strategy workshopOrganize a Strategy workshop gathering the experts, stakeholders, regulators and policy makers, including the members of the advisory board, to build up the ecosystem further (with WP4), and to define the strategy (policy, activities, priorities and timelines) required to reach the goals. Programme: H2020-EU.1.2.1. - Topic(s): FETOPEN-03-2017 |
Documents, reports | 2020-04-09 |
Current and future potential business modelsThis working group will identify business models and cases that are currently employed and discuss future alternatives for the commercialization of organ-on-a-chip technology. In a first step, an inventory of business models of commercial organ-on-a-chip providers will be made providing an overview of the current situation. Together with relevant stakeholders, these models will be categorized and evaluated in terms of strength and weaknesses. New business models will be developed using the “lean start-up†methodology and business model canvas. Programme: H2020-EU.1.2.1. - Topic(s): FETOPEN-03-2017 |
Documents, reports | 2020-04-09 |
Identification of training needsShifting assays from traditional cell culture or animal experiments to bioengineered advanced organ-on-a-chip systems will also change the type of work performed by the responsible researchers. This working group will identify interdisciplinary skills and experiences necessary to prepare young scientists for the utilization of organ-on-a-chip technologies in their future employments. Programme: H2020-EU.1.2.1. - Topic(s): FETOPEN-03-2017 |
Documents, reports | 2020-04-09 |
Guideline for the research communityPropose guidelines for research and use of organ-on-chip technology addressing stakeholders adequately. Programme: H2020-EU.1.2.1. - Topic(s): FETOPEN-03-2017 |
Documents, reports | 2020-04-09 |
Societal primer on ethical use and implicationsIdentify risks and opportunities of potential applications enabled by the research roadmap. Reveal stakeholder opinions (individual vs society, citizen vs patient, healthcare system, government, business, science) through literature study, expert consultations and workshops with different stakeholders (with WP2). Categorize ethical implications. Programme: H2020-EU.1.2.1. - Topic(s): FETOPEN-03-2017 |
Documents, reports | 2020-04-09 |
Primer on organ-on-chip – Desirable, safe & efficientA primer on organ-on-chip – Desirable, safe & efficient Programme: H2020-EU.1.2.1. - Topic(s): FETOPEN-03-2017 |
Documents, reports | 2020-04-09 |
Questionnaire for stakeholdersA deeper analysis of current customer segments, individual customers and the stakeholders within the customer businesses will be performed. One aim of this task is the development of stakeholder profiles across different established B2B customers and customer segments. Organ-on-chip systems are new cutting edge technologies currently designed for customers in the pharmaceutical industry. A second aim of this task is to look beyond the pharmaceutical industry to identify new markets that may have not been concerned by the scientists developing the technology. New markets will be explored using brainstorming and idea creation techniques such as opportunity redefinition, semantic intuition, forced relationships and brainwriting. In this way we may find completely new uses for the organ-on-chip technology that addresses unforeseen markets. Programme: H2020-EU.1.2.1. - Topic(s): FETOPEN-03-2017 |
Documents, reports | 2020-04-09 |
Policy paper on ethics, regulatory and standardizationOverall results on the three pillars of regulation, standardisation and ethics will be consolidated and presented in three formats. Programme: H2020-EU.1.2.1. - Topic(s): FETOPEN-03-2017 |
Documents, reports | 2020-04-09 |
Report on state-of-the-art and SWOT analysisAssess regulatory pathways used today, either on purpose or due to the lack of specific regulation. Identify best practises for the use and acceptance of processes, protocols, and supporting technology but in particularly explore shortcomings due to incompatibility and lack of standardisation. Chart the ethical discussion on organ-on-chip technology and areas that may be strongly affected by it (e.g. 3R). Programme: H2020-EU.1.2.1. - Topic(s): FETOPEN-03-2017 |
Documents, reports | 2020-04-09 |
Organ-on-chip as next drug discovery routeReport on organ-on-chip as next drug discovery route Programme: H2020-EU.1.2.1. - Topic(s): FETOPEN-03-2017 |
Documents, reports | 2020-04-09 |
Final dissemination planFinal dissemination plan for the scientific & industrial communities, and general public Programme: H2020-EU.1.2.1. - Topic(s): FETOPEN-03-2017 |
Documents, reports | 2020-04-09 |
Digital platformThe development of the digital platform will be a software coding activity consisting of developing all functionalities defined previously including user authentication, set-up of the search engine for data accessing, the user interface, etc. The digital platform will allow the search of data such as the European patents (patents of the European Patent Office), Scientific articles in Open Access (i.e. scientific articles accessible free of charge and not property of a publisher) and research. All information will be searchable with advanced semantic search tools, used by users through a simple mask for simple queries or through advanced research. Programme: H2020-EU.1.2.1. - Topic(s): FETOPEN-03-2017 |
Websites, patent fillings, videos etc. | 2020-04-09 |
Societal and economic impactThis task will give insight how to direct the development of organ-on-chip technology towards maximal societal and economic impact. This task will: Programme: H2020-EU.1.2.1. - Topic(s): FETOPEN-03-2017 |
Documents, reports | 2020-04-09 |
Website and project logoWesite and project logo (will be continuously updated). Programme: H2020-EU.1.2.1. - Topic(s): FETOPEN-03-2017 |
Websites, patent fillings, videos etc. | 2020-04-09 |
Report on vision workshopOrganize a Vision workshop (invitational, 25-50 participants, including the ORCHID advisory board) to define by consensus the desired and feasible short-term, mid-term and long-term goals and challenges of the roadmap taking into account the state-of-the-art, unmet needs, economic and societal impact (WP3). This will be based on scenario analysis in close dialogue with WP3 Programme: H2020-EU.1.2.1. - Topic(s): FETOPEN-03-2017 |
Documents, reports | 2020-04-09 |